Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8119607 Bicyclic nucleosides and nucleotides as therapeutic agents

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Paula Francom0

Jianmin Duan0

Michael Harding0

Michael John Lilly0

Richard Bethell0

Richard Hufton0

Saba Jahangiri0

Silas Bond0

...

Date of Patent

February 21, 2012

0

Patent Application Number

124963110

Date Filed

July 1, 2009

0

Patent Citations Received

US Patent 12116380 Phospholipid compounds and methods of making and using the same

0

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

0

US Patent 11707480 Highly active compounds against COVID-19

0

US Patent 11767337 Antiviral compounds

US Patent 11780844 Compounds and methods for treatment of viral infections

US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections

0

US Patent 11903953 Remdesivir treatment methods

0

US Patent 11926645 Compounds and methods for treatment of viral infections

0

...

Patent Primary Examiner

0

Patent abstract

The present disclosure relates to the use and methods of manufacture of bicyclic nucleosides and nucleotides for the treatment and prevention of infectious and proliferative diseases, including microbial infections and cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8119607 Bicyclic nucleosides and nucleotides as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool